# Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot

> **NCT02304588** · PHASE1 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Diabetic Foot
- Lower Limb Ischemia

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02304588
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-12
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02304588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02304588, "Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02304588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
